The Irish Stock Exchange notes United Drug’s announcement that its Board is reviewing the company’s listing arrangements to allow for potential inclusion in the FTSE UK Index Series. This review is prompted by the rules for inclusion in the FTSE UK Index Series, which require that at least 50% of trading in a constituent company’s […]
United Drug considers Irish delisting is a post from: Ireland Business